Bionet (ROCO:1784) Cyclically Adjusted FCF per Share: NT$ (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:1784 Bionet Corp ROCO:1784
80 GF Score
Price NT$58.00
GF Value NT$82.71
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Bionet Cyclically Adjusted FCF per Share?

Bionet ROCO:1784 -1.86% 80 Cyclically Adjusted FCF per Share is NT$ as of Jun. 2026. GuruFocus rates ROCO:1784 with a GF Score™ of 80/100 and a GF Value™ of NT$82.71 (Significantly Undervalued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Bionet's adjusted free cash flow per share for the three months ended in Jun. 2026 was NT$0.741. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is NT$ for the trailing ten years ended in Jun. 2026.

During the past 12 months, Bionet's average Cyclically Adjusted FCF Growth Rate was 184.20% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 32.60% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 14.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Bionet was 32.60% per year. The lowest was -9.10% per year. And the median was 21.05% per year.

As of today (2026-09-21), Bionet's current stock price is NT$58.00. Bionet's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2026 was NT$. Bionet's Cyclically Adjusted Price-to-FCF of today is .

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Bionet was 715.07. The lowest was 103.19. And the median was 196.62.


Bionet  (ROCO:1784) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Bionet was 715.07. The lowest was 103.19. And the median was 196.62.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Bionet Cyclically Adjusted FCF per Share Related Terms


Bionet Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Bionet's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bionet Cyclically Adjusted FCF per Share Chart

Bionet Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Bionet Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

ROCO:1784 vs TMO, DHR, NTRA: Cyclically Adjusted FCF per Share Comparison

For the Diagnostics & Research subindustry, Bionet's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bionet Cyclically Adjusted Price-to-FCF vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Bionet's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Bionet's Cyclically Adjusted Price-to-FCF falls into.


ROCO:1784
80GF Score
Bionet Corp ROCO:1784
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bionet Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Bionet's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.741/333.9520*333.9520
=0.741

Current CPI (Jun. 2026) = 333.9520.

Bionet Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201609 0.047 241.428 0.065
201612 -0.266 241.432 -0.368
201703 -0.277 243.801 -0.379
201706 -0.203 244.955 -0.277
201709 0.036 246.819 0.049
201712 -0.337 246.524 -0.457
201803 -0.104 249.554 -0.139
201806 0.004 251.989 0.005
201809 -0.421 252.439 -0.557
201812 0.292 251.233 0.388
201903 0.160 254.202 0.210
201906 0.029 256.143 0.038
201909 -0.117 256.759 -0.152
201912 0.646 256.974 0.840
202003 0.103 258.115 0.133
202006 -0.454 257.797 -0.588
202009 0.252 260.280 0.323
202012 0.289 260.474 0.371
202103 -0.424 264.877 -0.535
202106 0.087 271.696 0.107
202109 0.649 274.310 0.790
202112 -0.034 278.802 -0.041
202203 0.024 287.504 0.028
202206 0.365 296.311 0.411
202209 0.902 296.808 1.015
202212 0.780 296.797 0.878
202303 0.326 301.836 0.361
202306 1.199 305.109 1.312
202309 0.037 307.789 0.040
202312 1.250 306.746 1.361
202403 0.276 312.332 0.295
202406 -0.129 314.175 -0.137
202409 0.391 315.301 0.414
202412 1.363 315.605 1.442
202503 -0.074 319.799 -0.077
202506 0.252 322.561 0.261
202509 -0.028 324.800 -0.029
202512 0.185 324.054 0.191
202603 0.511 330.213 0.517
202606 0.741 333.952 0.741

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of NT$ mean?
Bionet (ROCO:1784) has a Cyclically Adjusted FCF per Share of NT$ as of Jun. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Bionet and its competitors.
Is Bionet's Cyclically Adjusted FCF per Share too high?
Bionet's current Cyclically Adjusted FCF per Share is NT$. Overall, Bionet has a GF Score™ of 80/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bionet's Cyclically Adjusted FCF per Share compare to TMO and DHR?
Bionet's Cyclically Adjusted FCF per Share of NT$ can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Diagnostics & Research company?
A good Cyclically Adjusted FCF per Share depends on the Medical Diagnostics & Research industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Bionet and its competitors. Bionet's current Cyclically Adjusted FCF per Share is NT$. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bionet stock overvalued right now?
Based on GuruFocus' analysis, Bionet (ROCO:1784) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$82.71, compared to a current price of NT$58.00 — trading 29.9% below its estimated fair value. The current Cyclically Adjusted FCF per Share is NT$. Bionet's overall GF Score™ is 80/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Bionet (ROCO:1784), the current Cyclically Adjusted FCF per Share is NT$ as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bionet (ROCO:1784) Overvalued in 2026?

Based on GuruFocus' analysis, Bionet stock appears to be undervalued. The current stock price of NT$58.00 is trading 29.9% below its estimated GF Value™ of NT$82.71. GuruFocus considers Bionet to be Significantly Undervalued.

Key valuation signals for ROCO:1784:

  • Cyclically Adjusted FCF per Share: NT$
  • GF Value™: NT$82.71 vs. price of NT$58.00 (29.9% below fair value)
  • GF Score™: 80/100 with 4 warning signs

No single metric tells the full story. See the ROCO:1784 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bionet Business Description

Address No.28, Lane 36, Xinhu 1st Road, Neihu District, Taipei, TWN, 114065
Bionet Corp provides blood bank and stem cell services. It is a preservation center for stem cells such as Umbilical Cord Mesenchymal Stem Cells and Dental Pulp Stem Cell Stem.
80GF Score

Get the complete analysis for ROCO:1784

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$58.00
Price
NT$82.71
GF Value